Lista de obras - Luis Arias - Dominio Público Uruguay

A 1-year retrospective review of ranibizumab for naive nonsubfoveal choroidal neovascularization secondary to age-related macular degeneration.

artículo científico publicado en 2009

As-needed treatment with ranibizumab 0.5 mg in patients with neovascular age-related macular degeneration

artículo científico publicado en 2011

Cytogenetic analysis of choroidal melanoma

artículo científico publicado en 2013

Delay in treating age-related macular degeneration in Spain is associated with progressive vision loss.

artículo científico publicado en 2008

Efficacy and Safety of an Aflibercept Treat-and-Extend Regimen in Treatment-Naïve Patients with Macular Oedema Secondary to Central Retinal Vein Occlusion (CRVO): A Prospective 12-Month, Single-Arm, Multicentre Trial

artículo científico publicado en 2018

Impact of lesion size on photodynamic therapy with verteporfin of predominantly classic lesions in age related macular degeneration.

artículo científico publicado en 2005

Intra and interobserver agreement in the classification of fundus autofluorescence patterns in geographic atrophy secondary to age-related macular degeneration.

artículo científico publicado en 2011

Intravitreal bevacizumab (Avastin) for choroidal neovascularisation secondary to pathological myopia: 6-month results.

artículo científico publicado en 2008

Intravitreal infliximab in patients with macular degeneration who are nonresponders to antivascular endothelial growth factor therapy.

artículo científico publicado en 2010

Intravitreal ranibizumab for choroidal neovascularization secondary to pathological myopia: 12-month follow-up

scientific article published on 30 June 2011

Long-term results of photodynamic therapy for the treatment of choroidal neovascularization secondary to angioid streaks.

artículo científico publicado en 2005

Management of Wet Age-Related Macular Degeneration in Spain: Challenges for Treat and Extend Implementation in Routine Clinical Practice

scientific article published on 30 September 2019

One-year results of a flexible regimen with ranibizumab therapy in macular degeneration: relationship with the number of injections

article

Optical coherence tomography analysis of a randomized study combining photodynamic therapy with intravitreal triamcinolone

scientific article published on 03 August 2007

Photodynamic therapy for chronic central serous chorioretinopathy

artículo científico publicado en 2009

Photodynamic therapy in subfoveal and juxtafoveal idiopathic and postinflammatory choroidal neovascularization

artículo científico publicado en 2006

Photodynamic therapy with intravitreal triamcinolone in predominantly classic choroidal neovascularization: one-year results of a randomized study

artículo científico publicado en 2006

Relative survival of patients with uveal melanoma managed in a single center

artículo científico publicado en 2012

Responses to ranibizumab in wet age-related macular degeneration patients with vitreomacular traction

artículo científico publicado en 2013

Retinal hemangioblastoma regression after single session of photodynamic therapy

artículo científico publicado en 2014

Spontaneous regression of small melanocytic choroidal tumor

artículo científico publicado en 2011

Subthreshold transpupillary thermotherapy in management of foveal subretinal fluid in small pigmented choroidal lesions.

artículo científico publicado en 2013

Three versus one intravitreal bevacizumab injections as initial protocol to treat myopic choroidal neovascularization

artículo científico publicado en 2011

Twelve-month outcome after one intravitreal injection of bevacizumab to treat myopic choroidal neovascularization.

artículo científico publicado en 2010

Update on Geographic Atrophy in Age-Related Macular Degeneration ⬇️

artículo científico publicado el 1 de julio de 2011

[Bullous retinal detachment in chronic central serous chorioretinopathy treated with photodynamic therapy]

artículo científico publicado en 2011

[Epidemiology of age-related macular degeneration. Situation in Spain]

artículo científico publicado en 2006

[Low-fluence photodynamic therapy in chronic central serous chorioretinopathy]

artículo científico publicado en 2011

Lista de obras de Luis Arias

A 1-year retrospective review of ranibizumab for naive nonsubfoveal choroidal neovascularization secondary to age-related macular degeneration.

As-needed treatment with ranibizumab 0.5 mg in patients with neovascular age-related macular degeneration

Cytogenetic analysis of choroidal melanoma

Delay in treating age-related macular degeneration in Spain is associated with progressive vision loss.

Efficacy and Safety of an Aflibercept Treat-and-Extend Regimen in Treatment-Naïve Patients with Macular Oedema Secondary to Central Retinal Vein Occlusion (CRVO): A Prospective 12-Month, Single-Arm, Multicentre Trial

Impact of lesion size on photodynamic therapy with verteporfin of predominantly classic lesions in age related macular degeneration.

Intra and interobserver agreement in the classification of fundus autofluorescence patterns in geographic atrophy secondary to age-related macular degeneration.

Intravitreal bevacizumab (Avastin) for choroidal neovascularisation secondary to pathological myopia: 6-month results.

Intravitreal infliximab in patients with macular degeneration who are nonresponders to antivascular endothelial growth factor therapy.

Intravitreal ranibizumab for choroidal neovascularization secondary to pathological myopia: 12-month follow-up

Long-term results of photodynamic therapy for the treatment of choroidal neovascularization secondary to angioid streaks.

Management of Wet Age-Related Macular Degeneration in Spain: Challenges for Treat and Extend Implementation in Routine Clinical Practice

One-year results of a flexible regimen with ranibizumab therapy in macular degeneration: relationship with the number of injections

Optical coherence tomography analysis of a randomized study combining photodynamic therapy with intravitreal triamcinolone

Photodynamic therapy for chronic central serous chorioretinopathy

Photodynamic therapy in subfoveal and juxtafoveal idiopathic and postinflammatory choroidal neovascularization

Photodynamic therapy with intravitreal triamcinolone in predominantly classic choroidal neovascularization: one-year results of a randomized study

Relative survival of patients with uveal melanoma managed in a single center

Responses to ranibizumab in wet age-related macular degeneration patients with vitreomacular traction

Retinal hemangioblastoma regression after single session of photodynamic therapy

Spontaneous regression of small melanocytic choroidal tumor

Subthreshold transpupillary thermotherapy in management of foveal subretinal fluid in small pigmented choroidal lesions.

Three versus one intravitreal bevacizumab injections as initial protocol to treat myopic choroidal neovascularization

Twelve-month outcome after one intravitreal injection of bevacizumab to treat myopic choroidal neovascularization.

Update on Geographic Atrophy in Age-Related Macular Degeneration ⬇️

[Bullous retinal detachment in chronic central serous chorioretinopathy treated with photodynamic therapy]

[Epidemiology of age-related macular degeneration. Situation in Spain]

[Low-fluence photodynamic therapy in chronic central serous chorioretinopathy]